A compound of the formula (I): wherein A is a hydrogen atom, an optionally substituted, unsaturated, N-containing heterocyclic group or a group of the formula (a): wherein R is an optionally substituted aryl group or an optionally substituted heterocyclic group; M is —(CH
2
)n-, —(CH
2
)n-O—(CH
2
)m-or —(CH
2
)n-NH—(CH
2
)m-, wherein n and m are independently 0, 1 or 2; Q is an optionally substituted cycloalkylene group, an optionally substituted arylene group or an optionally substituted divalent heterocyclic group; and the moiety of the formula (b): is an optionally substituted, unsaturated, mono-, di-, tri- or tetra-cyclic, N-containing heterocyclic group which may contain additional hetero atom(s) selected from the group consisting of nitrogen, oxygen and sulfur atoms as the ring member(s), its prodrug or a pharmaceutically acceptable salt thereof.
化合物的结构式为(I):其中A是氢原子,可选取代的不饱和含氮杂环基团或式(a)的基团:其中R是可选取代的芳基基团或可选取代的杂环基团;M是-(
CH2)n-,-( )n-O-( )m-或-( )n-NH-( )m-,其中n和m独立地为0、1或2;Q是可选取代的环烷基基团、可选取代的
芳烃基团或可选取代的二价杂环基团;以及式(b)的基团:是可选取代的、不饱和的、单环、双环、
三环或四环的、含氮的杂环基团,其中可能包含从氮、氧和
硫原子中选择的额外杂原子作为环成员,它的前药或其药学上可接受的盐。